221 related articles for article (PubMed ID: 30648105)
1. Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis.
Wang J; Li Y; Wang C; Zhang Y; Gao C; Lang H; Chen X
Biomed Res Int; 2018; 2018():1316096. PubMed ID: 30648105
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of rituximab for minors with immune thrombocytopenia: a systematic review and meta-analysis.
Qu M; Zhou J; Yang SJ; Zhou ZP
J Int Med Res; 2020 Oct; 48(10):300060520962348. PubMed ID: 33115308
[TBL] [Abstract][Full Text] [Related]
3. Anti-GPIb/IX autoantibodies are associated with poor response to dexamethasone combined with rituximab therapy in primary immune thrombocytopenia patients.
Ding B; Liu L; Li M; Song X; Zhang Y; Xia A; Liu J; Zhou H
Platelets; 2023 Dec; 34(1):2258988. PubMed ID: 37722393
[TBL] [Abstract][Full Text] [Related]
4. [Rituximab and Dexamethasone Combined with Cyclophosphamide for Treatment of Relapsed and Refractory Immune Thrombocytopenia].
Han XD; Zhou J; Yu FK; Fang BJ; Zhang YL; Wei XD; Song YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):162-6. PubMed ID: 26913414
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.
Zaja F; Baccarani M; Mazza P; Bocchia M; Gugliotta L; Zaccaria A; Vianelli N; Defina M; Tieghi A; Amadori S; Campagna S; Ferrara F; Angelucci E; Usala E; Cantoni S; Visani G; Fornaro A; Rizzi R; De Stefano V; Casulli F; Battista ML; Isola M; Soldano F; Gamba E; Fanin R
Blood; 2010 Apr; 115(14):2755-62. PubMed ID: 20130241
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options for adult patients with previously treated immune thrombocytopenia - a systematic review and network meta-analysis.
Yang R; Lin L; Yao H; Ji O; Shen Q
Hematology; 2019 Dec; 24(1):290-299. PubMed ID: 30661482
[TBL] [Abstract][Full Text] [Related]
7. The Efficacy of High-Dose Dexamethasone vs. Other Treatments for Newly Diagnosed Immune Thrombocytopenia: A Meta-Analysis.
Xiao Q; Lin B; Wang H; Zhan W; Chen P
Front Med (Lausanne); 2021; 8():656792. PubMed ID: 34113634
[No Abstract] [Full Text] [Related]
8. More about the combination of rituximab, cyclosporine and dexamethasone in the treatment of chronic ITP. A useful option on an environment with limited resources.
Thabet AF; Moeen SM
Platelets; 2020 Aug; 31(6):784-787. PubMed ID: 31603012
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.
Oved JH; Lee CSY; Bussel JB
J Pediatr; 2017 Dec; 191():225-231. PubMed ID: 29173312
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of treatments in newly diagnosed adult primary immune thrombocytopenia: A systematic review and network meta-analysis.
Wang Y; Sheng L; Han F; Guo Q; Zhang Z; Hou Y; Feng Q; Zhou H; Ji X; Peng J; Hou M; Xu M
EClinicalMedicine; 2023 Feb; 56():101777. PubMed ID: 36578882
[TBL] [Abstract][Full Text] [Related]
11. Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases.
Hindilerden F; Yönal-Hindilerden İ; Yenerel MN; Nalçacı M; Diz-Küçükkaya R
Turk J Haematol; 2017 Mar; 34(1):72-80. PubMed ID: 27102929
[TBL] [Abstract][Full Text] [Related]
12. Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis.
Chugh S; Darvish-Kazem S; Lim W; Crowther MA; Ghanima W; Wang G; Heddle NM; Kelton JG; Arnold DM
Lancet Haematol; 2015 Feb; 2(2):e75-81. PubMed ID: 26687612
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux.
Deshayes S; Khellaf M; Zarour A; Layese R; Fain O; Terriou L; Viallard JF; Cheze S; Graveleau J; Slama B; Audia S; Cliquennois M; Ebbo M; Le Guenno G; Salles G; Bonmati C; Teillet F; Galicier L; Lambotte O; Hot A; Lefrère F; Mahévas M; Canoui-Poitrine F; Michel M; Godeau B
Am J Hematol; 2019 Dec; 94(12):1314-1324. PubMed ID: 31489694
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of 19 drug therapies for patients with idiopathic thrombocytopenic purpura: a multiple-treatments network meta-analysis.
Zhou H; Fan J; He J; Hu S
Ann Hematol; 2022 May; 101(5):953-961. PubMed ID: 35149911
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for children with immune thrombocytopenia: a systematic review.
Liang Y; Zhang L; Gao J; Hu D; Ai Y
PLoS One; 2012; 7(5):e36698. PubMed ID: 22666325
[TBL] [Abstract][Full Text] [Related]
16. Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second-line treatment.
Chang H; Tang TC; Hung YS; Li PL; Kuo MC; Wu JH; Wang PN
Eur J Haematol; 2018 Oct; 101(4):549-555. PubMed ID: 30007087
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
Depré F; Aboud N; Mayer B; Salama A
PLoS One; 2018; 13(6):e0198184. PubMed ID: 29856800
[TBL] [Abstract][Full Text] [Related]
18. Comparative treatment-related adverse event cost burden in immune thrombocytopenic purpura.
Donga PZ; Bilir SP; Little G; Babinchak T; Munakata J
J Med Econ; 2017 Nov; 20(11):1200-1206. PubMed ID: 28882075
[TBL] [Abstract][Full Text] [Related]
19. High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis.
Mithoowani S; Gregory-Miller K; Goy J; Miller MC; Wang G; Noroozi N; Kelton JG; Arnold DM
Lancet Haematol; 2016 Oct; 3(10):e489-e496. PubMed ID: 27658982
[TBL] [Abstract][Full Text] [Related]
20. Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia.
Gudbrandsdottir S; Birgens HS; Frederiksen H; Jensen BA; Jensen MK; Kjeldsen L; Klausen TW; Larsen H; Mourits-Andersen HT; Nielsen CH; Nielsen OJ; Plesner T; Pulczynski S; Rasmussen IH; Rønnov-Jessen D; Hasselbalch HC
Blood; 2013 Mar; 121(11):1976-81. PubMed ID: 23293082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
